Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ...

Peethaambaran Kunnathoor, Chennai Saturday, November 16, 2024, 08:00 Hrs [IST] ...

Nandita Vijayasimha, Bengaluru Saturday, November 16, 2024, 08:00 Hrs [IST] ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

NCCE recommends reports generated by automatic analyser can be signed by technician: Our Bureau, New Delhi Saturday, November 16, 2024, 08:00 Hrs [IST] The National Council for Cl ...

New technologies and treatments revolutionizing diabetes care: Dr Ajay Aggarwal: Shardul Nautiyal, Mumbai Saturday, November 16, 2024, 08:00 Hrs [IST] As diabetes continues to ris ...

Azurity Pharma gets US FDA approval for Danziten tablets, the first and only nilotinib with no mealtime restrictions: Woburn, Massachusetts Saturday, November 16, 2024, 17:00 Hrs ...

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, announced that the first participant has been vaccinated in a ...

LEO Pharma’s Anzupgo cream to treat chronic hand eczema receives marketing approval in Switzerland: Ballerup, Denmark Saturday, November 16, 2024, 15:00 Hrs [IST] LEO Pharma A/S ...

AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...